Encision raises $80K to fund operations at its surgical safety business
What's the deal? EncisionDealroom has a profile for this one. Try Dealroom →, a Boulder, Colorado medical device company, has completed an $80,000 private placement of common stock. It closed the deal on September 8, 2026, issuing 2 million restricted shares to a group of private investors.
Who bought in? The investor group consisted entirely of the company's directors. The shares carry no registration rights.
What's the money for? "We are pleased to have secured necessary funds for general working capital purposes," said Robert Fries, interim president and chief executive officer of Encision.
What's the endgame? Encision owns patented Active Electrode Monitoring (AEM) technology, which prevents dangerous stray energy burns during minimally invasive surgery. It designs and markets surgical instrumentation to hospitals across a range of procedures.
Following the placement, Encision has 18,879,645 common shares outstanding. Its stock trades over the counter under the ticker ECIA.
The signal: A small, director-backed raise for working capital shows Encision leaning on insiders to keep operations funded — a modest but telling vote of confidence from its own board.
Image credit: NavyMedicine
